![](/accounts/acos/images/acos-logo.png)
Innovations and Treatment in Pediatric Cerebrovascular Disease and Stroke
Key:
![](/images/product-status-icons/complete-small.png)
![](/images/product-status-icons/next-small.png)
![](/images/product-status-icons/disabled-small.png)
![](/images/product-status-icons/optional-small.png)
![](/images/product-status-icons/locked-small.png)
Session Evaluation Survey
5 Questions
5 Questions
Physicians eligible to earn CME for participation in this activity can earn AOA Category 1-A Credit hours or AMA PRA Category 1 CreditTM. In order to claim CME credits for this session, registrants must evaluate each lecture attended. CME hours attended at the meeting will be tracked through this online evaluation system.
- Identify current difficulties in management of pediatric stroke
- Application of various management strategies in PCVDS
- Recognize importance in molecular and genetic basis towards PCVDS management practice
![Speaker image](https://www.conferenceharvester.com/uploads/harvester/photos/cropVJWBYRFN-Presenter-VadiveluS.jpg)
Sudhakar Vadivelu, DO
Neurosurgeon
Cincinnati Children's Hospital Medical Center
As a pediatric endovascular neurosurgeon, I’m trained to deliver both open and endovascular (minimally invasive) approaches for curing vascular disorders of the brain and spinal cord in children. I am also trained in interventional neuroradiology to deliver these endovascular angiographic based evaluation treatments. I was inspired to pursue my career by the shortage of information and the controversy in caring for children with vascular disorders and stroke of the brain and spinal cord.
I’m the director of the Pediatric Cerebrovascular Disease and Stroke Center at Cincinnati Children’s. We have a strong history in multidisciplinary pediatric care at every visit. I also serve as a physician scientist attempting to create an innovative patient-specific treatment in the basic science research lab and translate these cutting-edge discoveries in a safe, effective manner for childhood care solutions.
I was chosen as one of Cincinnati Business Courier’s top Forty Under 40 in surgical innovation.
My research focuses on overcoming identifiable genes responsible for abnormal brain vessel development and increased stroke risk. We also want to harness white-matter plasticity and neural stem cell regeneration as potential treatment approaches.
You must be logged in to post to the discussion